AVAI BIO, INC.: 10-Q filed 2019-11-13
What AVAI BIO, INC. reported in its quarterly report filed 2019-11-13 (fiscal Q2 2020): 22 published measures, 54 facts as tagged in accession 0001740797-19-000031.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-11-13
- Fiscal period
- fiscal Q2 2020
- Accession
- 0001740797-19-000031 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AVAI BIO, INC. filings.
Reported measures
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 99,254 | USD | |
| At 2019-03-31 | 30,523 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -122,491 | USD | |
| At 2019-06-30 | -91,498 | USD | |
| At 2019-03-31 | -49,612 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 701 | USD | |
| At 2019-03-31 | 102 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -30,993 | USD | 92 |
| 2019-04-01 to 2019-06-30 | -41,886 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-09-30 | -37,328 | USD | 183 |
| 2018-04-01 to 2018-09-30 | -73,412 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-09-30 | -89,283 | USD | 183 |
| 2018-04-01 to 2018-09-30 | -9,861 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -151,843 | USD | |
| At 2019-03-31 | -78,964 | USD |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 5,014,080 | shares | 92 |
| 2019-04-01 to 2019-09-30 | 5,014,080 | shares | 183 |
| 2018-07-01 to 2018-09-30 | 2,234,536 | shares | 92 |
| 2018-04-01 to 2018-09-30 | 960,641 | shares | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 99,254 | USD | |
| At 2019-03-31 | 30,523 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 26,400 | USD | |
| At 2019-03-31 | 6,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 30,993 | USD | 92 |
| 2019-04-01 to 2019-09-30 | 78,879 | USD | 183 |
| 2018-07-01 to 2018-09-30 | 26,716 | USD | 92 |
| 2018-04-01 to 2018-09-30 | 31,956 | USD | 183 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 0 | USD | 92 |
| 2019-04-01 to 2019-09-30 | 6,000 | USD | 183 |
| 2018-07-01 to 2018-09-30 | 0 | USD | 92 |
| 2018-04-01 to 2018-09-30 | 0 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 0 | USD | 92 |
| 2019-04-01 to 2019-09-30 | 27,040 | USD | 183 |
| 2018-07-01 to 2018-09-30 | 0 | USD | 92 |
| 2018-04-01 to 2018-09-30 | 0 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 5,014,080 | shares | |
| At 2019-03-31 | 5,014,080 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 24,338 | USD | |
| At 2019-03-31 | 24,338 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 325 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 8,117 | USD | |
| At 2019-03-31 | 0 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 89,283 | USD | |
| At 2019-03-31 | 3,733 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 55 | USD | |
| At 2019-03-31 | 55 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 3,229 | USD | 92 |
| 2019-04-01 to 2019-09-30 | 12,534 | USD | 183 |
| 2018-07-01 to 2018-09-30 | 20,344 | USD | 92 |
| 2018-04-01 to 2018-09-30 | 20,483 | USD | 183 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-09-30 | 3,884 | USD | 183 |
| 2018-04-01 to 2018-09-30 | 472 | USD | 183 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-09-30 | 20,319 | USD | 183 |
| 2018-04-01 to 2018-09-30 | 63 | USD | 183 |
Inspect the source
- Entity
- AVAI BIO, INC. / CIK 0001740797
- Captured
- 2026-09-21T17:25:43.217Z
- SEC response SHA-256
517998bc0cdcf6cacd8a8d0f1fd509d15f40cb7868ef1a28e1bc010be8dc1c03
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001740797.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))